|Bid||37.46 x 1400|
|Ask||37.72 x 1000|
|Day's range||35.88 - 37.90|
|52-week range||27.38 - 174.32|
|Beta (5Y monthly)||0.81|
|PE ratio (TTM)||N/A|
|Earnings date||25 Jul 2022 - 29 Jul 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||58.02|
In this video, I will be talking about Teladoc Health (NYSE: TDOC) and whether it is a buy right now. The stock is down 60% year to date, and its most recent quarter was not its best, but if you are risk tolerant and have a long-term view, this is a company you might want to take a look at.
Telemedicine specialist Teladoc (NYSE: TDOC) has had a rough go of it in the past year. While marketwide issues (inflation, geopolitical tensions, etc.) have undoubtedly played a role, Teladoc faces headwinds of its own. Let's look at one reason to be bullish on Teladoc stock and one reason investors might want to look elsewhere.
With the Federal Reserve aggressively hiking interest rates and the stock market in a steady decline, it's entirely rational to wonder whether it's a good idea to keep buying shares of growth-phase businesses. Let's examine Teladoc Health (NYSE: TDOC) as an example to explore which category of investor you might fall into during the ongoing disruption in the market and the economy. Like many other growth stocks, Teladoc is down more than 88% over the last 12 months.